Rx To Go Earns Three-Year Accreditation with Distinction in Oncology Care

Rx To Go Achieves Prestigious Accreditation with ACHC

Rx To Go, LLC, the in-house specialty pharmacy for the Florida Cancer Specialists & Research Institute, has recently secured its re-accreditation from the Accreditation Commission for Health Care (ACHC) for its pharmacy services, earning distinction in the field of oncology. This impressive accolade underscores the pharmacy's unyielding commitment to maintaining the highest standards in patient safety and operational excellence.

The three-year accreditation is a testament to Rx To Go's rigorous adherence to ACHC’s national standards, which are designed to enhance healthcare practices. "Achieving another three-year pharmacy accreditation with distinction in oncology reaffirms our organization's commitment to the highest standards of safety, quality, and operational excellence," stated Paul Chadwick, Chief Value and Procurement Officer at Florida Cancer Specialists.

The importance of accreditation cannot be overstated. It reflects an organization’s dedication to improving performance and ensuring optimal patient care, validating the expertise of its professionals. The ACHC has served as a hallmark of quality in healthcare since its inception in 1986 and is noted for its ISO 9001:2015 certification.

Furthermore, Rx To Go's pharmacy program plays a crucial role in delivering quality treatment options to cancer patients. Ryan Ciarrocchi, CEO of Florida Cancer Specialists, expressed, "Earning accreditation with distinction is a significant achievement that exemplifies Rx To Go's continuous pursuit of excellence in oncology care. It highlights the crucial role our pharmacy program plays in advancing treatment quality, safety, and innovation for patients."

This recognition not only reinforces the pharmacy’s ongoing mission to deliver superior health outcomes but also positions it as a benchmark for community oncology practices across the United States. Rx To Go has built a reputation for its extensive access to oncology drugs, with 99% of all oral oncology medications being available to patients. It also offers around-the-clock patient support, ensuring that assistance is always at hand for those in need.

In 2024, the pharmacy dispensed nearly 100,000 prescriptions, underscoring its role in patient care delivery through Florida Cancer Specialists. The pharmacy also holds accreditation from URAC for specialty pharmacy and a dual accreditation from the National Association of Boards of Pharmacy (NABP) for both specialty and digital pharmacy practices.

For over 40 years, Florida Cancer Specialists has led the way in oncology care, continually innovating to improve patient outcomes. Their robust clinical research program has established them as a premier provider of clinical trials, allowing patients access to groundbreaking treatments prior to their FDA approval. This commitment to offering cutting-edge therapeutic options is a cornerstone of their practice, reflecting the broader dedication of their team towards personalized patient care.

Rx To Go's recent achievements exemplify their unwavering resolve to adhere to the highest standard of care, reinforcing their position as leaders in oncology pharmacy services. As they move forward, the focus remains on enhancing the quality of life for patients battling cancer through dedicated support and leading treatment options.